Milestone Pharmaceuticals Stock Market Value
| MIST Stock | USD 1.85 0.01 0.54% |
| Symbol | Milestone |
Milestone Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Milestone Pharmaceuticals. If investors know Milestone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Milestone Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Quarterly Revenue Growth (1.00) | Return On Assets (0.33) | Return On Equity (1.34) |
The market value of Milestone Pharmaceuticals is measured differently than its book value, which is the value of Milestone that is recorded on the company's balance sheet. Investors also form their own opinion of Milestone Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Milestone Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Milestone Pharmaceuticals' market value can be influenced by many factors that don't directly affect Milestone Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Milestone Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Milestone Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Milestone Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Milestone Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Milestone Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Milestone Pharmaceuticals.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Milestone Pharmaceuticals on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Milestone Pharmaceuticals or generate 0.0% return on investment in Milestone Pharmaceuticals over 30 days. Milestone Pharmaceuticals is related to or competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, Transcode Therapeutics, and Quoin Pharmaceuticals. Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiov... More
Milestone Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Milestone Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Milestone Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.24 | |||
| Information Ratio | 0.1392 | |||
| Maximum Drawdown | 18.66 | |||
| Value At Risk | (2.11) | |||
| Potential Upside | 7.19 |
Milestone Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Milestone Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Milestone Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Milestone Pharmaceuticals historical prices to predict the future Milestone Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1367 | |||
| Jensen Alpha | 0.354 | |||
| Total Risk Alpha | 0.1615 | |||
| Sortino Ratio | 0.183 | |||
| Treynor Ratio | 0.2989 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Milestone Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Milestone Pharmaceuticals Backtested Returns
Milestone Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Milestone Pharmaceuticals has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Milestone Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Milestone Pharmaceuticals' Downside Deviation of 2.24, mean deviation of 1.97, and Risk Adjusted Performance of 0.1367 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Milestone Pharmaceuticals holds a performance score of 9. The company secures a Beta (Market Risk) of 1.66, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Milestone Pharmaceuticals will likely underperform. Please check Milestone Pharmaceuticals' maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Milestone Pharmaceuticals' current price movements will revert.
Auto-correlation | 0.03 |
Virtually no predictability
Milestone Pharmaceuticals has virtually no predictability. Overlapping area represents the amount of predictability between Milestone Pharmaceuticals time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Milestone Pharmaceuticals price movement. The serial correlation of 0.03 indicates that only 3.0% of current Milestone Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.03 | |
| Spearman Rank Test | -0.56 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Milestone Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Milestone Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Milestone Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Milestone Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Milestone Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Milestone Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Milestone Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Milestone Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Milestone Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Milestone Pharmaceuticals Lagged Returns
When evaluating Milestone Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Milestone Pharmaceuticals stock have on its future price. Milestone Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Milestone Pharmaceuticals autocorrelation shows the relationship between Milestone Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Milestone Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.